© 2026 Forbes Media LLC. All Rights Reserved.
© 2026 Forbes Media LLC. All Rights Reserved.
ZUG, Switzerland and BOSTON, March 11, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics AG (Nasdaq: CRSP) (the "Company") today announced the pricing of $550 million aggregate principal amount of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results